A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center,
 double-masked, randomized, placebo controlled parallel treatment conjunctival allergen
 challenge (CAC) study in patients with allergic conjunctivitis
Study will evaluate the efficacy of nasal anti-allergic therapy compared to ocular
 anti-allergic therapy in the prevention of ocular allergic symptoms.
Inclusion Criteria:

 -  At least 18 years of age & either sex, any race

 -  Willing and able to follow all instructions and attend all study visits

 -  Positive history of ocular allergies

 -  Reproducible positive ocular allergic reaction induced by conjunctival allergen
 challenge

 Exclusion Criteria:

 -  Have planned surgery during trial period

 -  Female currently pregnant, planning a pregnancy, or lactating

 -  Use of disallowed medications